Obermatt
See Similar Stocks →

Anbio Biotechnology

NMQ:NNNN · KYG0367B1059
BiotechnologySmall

360° View

no current rank
Price/Sales5
Price/Earnings1
Price/Book3
Dividend Yield1
Revenue Growth12
Profit Growth49
Capital Growth42
TSR 52w100
Leverage50
Liquidity—
Refinancing48
Combined—
Analyst Opinions—
Pro Holdings3
Opinion Changes—
Market Pulse3

Profile

CountryGermany
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded2021
Websiteanbiobiotechnology.com
ISINKYG0367B1059
Last UpdateApr 2, 2026
Index & Theme
GeneticsRespiratoryHealth DiagnosticsInfectious DiseasesDiabetesCardiovascularOncology

Description

Anbio Biotechnology (Anbio) provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. The company is dedicated to the advancement of medical technology and the pr…

Similar Stocks

The companies this stock is ranked against.

Compare Anbio Biotechnology with its peers
Pentixapharm
GER:PTP
22
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeX-Small
Full Stock Analysis →
SHL Telemedicine
SWX:SHLTN
24
CountryIsrael
IndustryHealth Care Providers & Services
SizeX-Small
Full Stock Analysis →
Stratec
GER:SBS
36
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
NewAmsterdam Pharma Company
NMQ:NAMS
16
CountryNetherlands
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Pharming
AEX:PHARM
77
CountryNetherlands
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
NovoCure
NSQ:NVCR
42
CountryJersey
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →